ASCO 2019 VIDEO: J. Leonard Lichtenfeld, MD
J. Leonard Lichtenfeld, MD, Acting Chief Medical and Scientific Officer, American Cancer...
Read MoreJul 10, 2019
J. Leonard Lichtenfeld, MD, Acting Chief Medical and Scientific Officer, American Cancer...
Read MoreJul 10, 2019
Catherine M. Diefenbach, MD, ASCO Spokesperson; NYU Langone Health William Dale, MD, PhD, ASCO...
Read MoreJul 10, 2019
Monica M. Bertagnolli, MD, Immediate Past-President, ASCO
Read MoreJul 10, 2019
Goals include disease prevention, switch to at-home dialysis, early transplants
Read MoreJul 10, 2019
Findings based on patient reports, although effect greater in men
Read MoreJul 10, 2019
Nearly 25 percent of patients meet treatment criteria, but only 5 percent get prescription
Read MoreJul 10, 2019
Improvements in high-risk moms and babies seen with modest improvements in nutritional content
Read MoreJul 10, 2019
Findings based on U.S. county-level data, independent of opioid prescription rates
Read MoreJul 10, 2019
Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT
Read MoreJul 10, 2019
Among opioid-naive patients, 8.4 percent of those who filled an initial opioid Rx had persistent use
Read MoreJul 10, 2019
Twofold higher risk for cancer seen for children, young adults with congenital heart disease
Read MoreJul 10, 2019
In large trial and literature review, benefit seen for depression but not anxiety symptoms
Read MoreJul 10, 2019
Risk assessment should consider infants born at ≥35 0/7 weeks and ≤34 6/7 weeks separately
Read MoreJul 10, 2019
Algorithms use data from EHRs to identify candidates for preexposure prophylaxis
Read MoreJul 10, 2019
Minimum-volume standards could restrict care at many centers with better-than-expected outcomes
Read MoreJul 10, 2019
Mean reduction in weekly frequency of cluster headache attacks greater with galcanezumab versus placebo
Read MoreJul 10, 2019
Activities included reading books, using computers, social or craft activities, and playing games
Read MoreJul 10, 2019
Remdesivir, ZMapp monoclonal antibodies both appear to block growth of the Ebola virus strain
Read MoreJul 9, 2019
Cancer risk up for MS patients versus non-MS controls, especially in respiratory, urinary, CNS organs
Read MoreJul 9, 2019
A smaller number of new cases was reported than has been typical this spring
Read More